ArticleJournal of the National Cancer Institute2022

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.

Lieske H Schrijver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.